thiophenes has been researched along with Alveolitis, Fibrosing in 15 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 10 (66.67) | 29.6817 |
| 2010's | 5 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bauer, Y; Bolli, MH; Gatfield, J; Killer, N; Menyhart, K; Nayler, O; Renault, B; Sobel, K; Steiner, B; Studer, R | 1 |
| Barbaro Foschino, MP; Brunetti, ND; Correale, M; Di Biase, M; Lacedonia, D; Montrone, D; Totaro, A | 1 |
| Alacam, H; Duran, L; Gunaydin, M; Guzel, A; Kayhan, S; Murat, N; Selcuk, MY; Torun, AC; Tutuncu, S; Yilmaz, MZ | 1 |
| Boccalini, G; Calosi, L; Durante, M; Lanzi, C; Lucarini, L; Mannaioni, G; Masini, E; Moroni, F; Pini, A | 1 |
| Cobanoğlu, B; Deveci, F; Erden, ES; Ilhan, N; Kirkil, G; Muz, MH; Turgut, T | 1 |
| Andersohn, F; Garbe, E | 1 |
| Bellamy, CO; Dhaun, N; Kluth, DC; MacIntyre, IM | 1 |
| Karapolat, S | 1 |
| Fujimura, M; Ichikawa, Y; Inuzuka, K; Nakao, S; Nishizawa, Y; Tagami, A; Takato, H; Waseda, Y; Yasui, M | 1 |
| Akyol, O; Armutcu, F; Iraz, M; Kaplan, S; Kart, L; Ozen, S; Ozyurt, H; Sogut, S; Temel, I; Yildirim, Z | 1 |
| Akyol, O; Armutcu, F; Aydogdu, I; Gurel, A; Iraz, M; Kotuk, M; Ozen, S; Turkoz, Y; Yildirim, Z | 1 |
| Armutcu, F; Iraz, M; Kotuk, M; Kuku, I; Ozen, S; Ulu, R; Yildirim, Z | 1 |
| Başyiğit, I; Boyaci, H; Dillioğlugil, MO; Erçin, C; Maral, H; Pala, A; Tugay, M; Turan, G; Yildiz, F | 1 |
| Ewert, R; Opitz, CF | 1 |
| Boichot, E; Caulet-Maugendre, S; Corbel, M; Germain, N; Lagente, V; Molet, S | 1 |
2 review(s) available for thiophenes and Alveolitis, Fibrosing
| Article | Year |
|---|---|
Novelty in treatment of pulmonary fibrosis: pulmonary hypertension drugs and others.
Topics: Antihypertensive Agents; Bosentan; Humans; Isoxazoles; Phenylpropionates; Phosphodiesterase Inhibitors; Pulmonary Fibrosis; Pyridazines; Sulfonamides; Thiophenes | 2013 |
Dual ET(A)/ET(B) vs. selective ET(A) endothelin receptor antagonism in patients with pulmonary hypertension.
Topics: Antihypertensive Agents; Bosentan; Cell Division; Endothelin A Receptor Antagonists; Endothelin B Receptor Antagonists; Endothelin Receptor Antagonists; Endothelin-1; Humans; Hypertension, Pulmonary; Isoxazoles; Lung; Pulmonary Fibrosis; Sulfonamides; Thiophenes; Vasoconstriction; Vasodilation | 2006 |
13 other study(ies) available for thiophenes and Alveolitis, Fibrosing
| Article | Year |
|---|---|
Sphingosine 1-phosphate (S1P) receptor agonists mediate pro-fibrotic responses in normal human lung fibroblasts via S1P2 and S1P3 receptors and Smad-independent signaling.
Topics: Actins; Animals; CHO Cells; Cricetinae; Cricetulus; Down-Regulation; Extracellular Matrix; Humans; Lung; Lysophospholipids; Mitogen-Activated Protein Kinase 1; Mitogen-Activated Protein Kinase 3; Myofibroblasts; Organophosphates; Oxadiazoles; Phosphatidylinositol 3-Kinases; Proto-Oncogene Proteins c-akt; Pulmonary Fibrosis; Receptors, Lysosphingolipid; Signal Transduction; Smad2 Protein; Smad3 Protein; Sphingosine; Thiazoles; Thiophenes; Transforming Growth Factor beta1 | 2013 |
Attenuation of bleomycin induced lung fibrosis by erdosteine and inhibition of the inducible nitric oxide synthase.
Topics: Acute Lung Injury; Animals; Bleomycin; Drug Therapy, Combination; Enzyme Inhibitors; Expectorants; Injections, Intraperitoneal; Isothiuronium; Lung; Male; Nitric Oxide Synthase Type II; Pulmonary Fibrosis; Random Allocation; Rats; Rats, Sprague-Dawley; Thioglycolates; Thiophenes; Tumor Necrosis Factor-alpha | 2015 |
HYDAMTIQ, a selective PARP-1 inhibitor, improves bleomycin-induced lung fibrosis by dampening the TGF-β/SMAD signalling pathway.
Topics: Actins; Animals; Biomarkers; Bleomycin; Fibroblasts; Hydroxyproline; Inflammation Mediators; Isoquinolines; Lung; Male; Mice, Inbred C57BL; Oxidative Stress; Poly(ADP-ribose) Polymerase Inhibitors; Poly(ADP-ribose) Polymerases; Pulmonary Fibrosis; Signal Transduction; Smad Proteins; Thiophenes; Transforming Growth Factor beta | 2017 |
[Effects of erdosteine on inflammation and fibrosis in rats with pulmonary fibrosis induced by bleomycin].
Topics: Animals; Bleomycin; Bronchoalveolar Lavage Fluid; Chemokines; Expectorants; Humans; Male; Pulmonary Fibrosis; Random Allocation; Rats; Rats, Wistar; Thioglycolates; Thiophenes | 2008 |
Cardiac and noncardiac fibrotic reactions caused by ergot-and nonergot-derived dopamine agonists.
Topics: Aged; Aged, 80 and over; Apomorphine; Benzothiazoles; Bromocriptine; Cabergoline; Databases, Factual; Dopamine Agonists; Endomyocardial Fibrosis; Ergolines; Female; Fibrosis; Heart Valve Diseases; Humans; Indoles; Male; Middle Aged; Pergolide; Pericarditis; Pleural Diseases; Pramipexole; Pulmonary Fibrosis; Retroperitoneal Fibrosis; Tetrahydronaphthalenes; Thiophenes; United States | 2009 |
Endothelin receptor antagonism and renin inhibition as treatment options for scleroderma kidney.
Topics: Amides; Antihypertensive Agents; Atrophy; Biomarkers; Biopsy; Endothelin Receptor Antagonists; Female; Fibrosis; Fumarates; Humans; Hypertension, Renal; Isoxazoles; Kidney; Middle Aged; Proteinuria; Pulmonary Fibrosis; Renal Insufficiency, Chronic; Renin; Scleroderma, Systemic; Thiophenes; Treatment Outcome | 2009 |
[Effects of erdosteine on inflammation and fibrosis in rats with pulmonary fibrosis induced by bleomycin].
Topics: Animals; Bleomycin; Expectorants; Pulmonary Fibrosis; Rats; Thioglycolates; Thiophenes | 2009 |
The specific chymase inhibitor TY-51469 suppresses the accumulation of neutrophils in the lung and reduces silica-induced pulmonary fibrosis in mice.
Topics: Animals; Bronchoalveolar Lavage Fluid; Chemokine CCL2; Chemokines, CC; Chymases; Cytokines; Hydroxyproline; Macrophage Inflammatory Proteins; Male; Mast Cells; Mice; Mice, Inbred ICR; Neutrophils; Pulmonary Fibrosis; Serine Endopeptidases; Silicon Dioxide; Sulfonamides; Thiophenes; Transforming Growth Factor beta1 | 2011 |
Erdosteine prevents bleomycin-induced pulmonary fibrosis in rats.
Topics: Animals; Antibiotics, Antineoplastic; Antioxidants; Bleomycin; Glutathione Peroxidase; Hydroxyproline; Lung; Male; Malondialdehyde; Oxidative Stress; Peroxidase; Pulmonary Fibrosis; Rats; Rats, Sprague-Dawley; Superoxide Dismutase; Thioglycolates; Thiophenes; Vitamin E | 2004 |
Effects of aminoguanidine and antioxidant erdosteine on bleomycin-induced lung fibrosis in rats.
Topics: Animals; Antioxidants; Bleomycin; Drug Therapy, Combination; Glutathione Peroxidase; Guanidines; Male; Malondialdehyde; Nitric Oxide; Peroxidase; Pulmonary Fibrosis; Rats; Rats, Sprague-Dawley; Superoxide Dismutase; Thioglycolates; Thiophenes; Tyrosine | 2004 |
Attenuation of bleomycin-induced lung fibrosis by oral sulfhydryl containing antioxidants in rats: erdosteine and N-acetylcysteine.
Topics: Acetylcysteine; Animals; Antioxidants; Bleomycin; Disease Models, Animal; Drug Interactions; Male; Pulmonary Fibrosis; Rats; Rats, Sprague-Dawley; Sulfhydryl Compounds; Thioglycolates; Thiophenes | 2005 |
Effects of erdosteine on bleomycin-induced lung fibrosis in rats.
Topics: Acute Lung Injury; Animals; Biomarkers; Bleomycin; Bronchoalveolar Lavage Fluid; Male; Oxidative Stress; Pulmonary Fibrosis; Rats; Rats, Sprague-Dawley; Thioglycolates; Thiophenes | 2006 |
Inhibition of bleomycin-induced pulmonary fibrosis in mice by the matrix metalloproteinase inhibitor batimastat.
Topics: Animals; Bleomycin; Body Weight; Bronchoalveolar Lavage Fluid; Cell Count; Hydroxyproline; Male; Matrix Metalloproteinase Inhibitors; Metalloendopeptidases; Mice; Mice, Inbred Strains; Phenylalanine; Protease Inhibitors; Pulmonary Fibrosis; Survival Rate; Thiophenes; Tissue Inhibitor of Metalloproteinases | 2001 |